# First Time in Human Study

> **NCT01031186** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Depressive Disorder and Anxiety Disorders

## Interventions

- **DRUG:** GSK356278
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT01031186
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-23
- **Primary completion:** 2010-04-07
- **Final completion:** 2010-04-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01031186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01031186, "First Time in Human Study". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01031186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*